ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 698959 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 698959; 2) Community: the network communities that were significantly associated with the response to NSC 698959; 3) Molecule: the relationships between components within communities and NSC 698959; 4) MDR: the compounds that were significantly associated with the NSC 698959.

NSC Compound Enrichment Correlation
NSC 717468 Null 0.0217366743178497 0.09403034
NSC 718781 Erlotinib hydrochloride 0.0217366743178497 -0.16457947
NSC 725098 Null 0.0217366743178497 0.23059245
NSC 726217 Combretastatin A4-analogue 0.0217366743178497 0.29746821
NSC 726442 4,11-dihydroxy-3-{[4-(2-hydroxyethyl)-1-piperazinyl]methyl}- 1H-naphtho[2,3-f]indole-5,10-dione dihydrochloride 0.0217366743178497 0.27303845
NSC 731701 1[(4-n-butyloxyCarbonyl)piperazine-1-yl]diazene-1-ium-1,2-di olate 0.0217366743178497 -0.00553688
NSC 731704 1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. 0.0217366743178497 0.17852835
NSC 732205 Null 0.0217366743178497 0.54641044
NSC 741425 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide 0.0217366743178497 0.41877964
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0217366743178497 0.36431227
Total:139  Current:78    [First] [Prev] [Next] [Last]